Why Semaglutide Causes Heartburn — and What Actually Helps

Gastric slowing is the root cause: semaglutide deliberately delays stomach emptying as part of how it reduces appetite — reflux is a direct consequence of that mechanism.
Usually most noticeable early on: symptoms tend to peak in the first days after starting or after a dose increase, then ease as your digestive system adapts.
Meal size and timing matter more than medicine: eating smaller portions, avoiding lying down soon after eating, and cutting back on fatty or spicy food can significantly reduce reflux on treatment.
Persistent or severe heartburn warrants a prescriber review: if symptoms are stopping you eating or sleeping, your prescriber can assess whether a slower titration or additional support is appropriate.

Semaglutide slows the rate at which your stomach empties food into the small intestine, and that delay is the main reason heartburn develops. Acid that would normally move through quickly lingers longer near the lower oesophageal sphincter, and reflux follows. This is a known, documented effect: the NHS medicines page for semaglutide lists indigestion, burping and reflux among the recognised side effects of treatment. The good news is that for most people it settles as the body adjusts, and a few practical habits can make a real difference while it does. These are prescription-only medicines, so how you manage the symptom and whether you continue treatment is a conversation for your prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The mechanism, the evidence, and practical steps that actually help

What the trial data and NHS guidance say about reflux on semaglutide

The STEP 1 trial (one of the pivotal studies behind Wegovy's licence, published in the New England Journal of Medicine) found that gastrointestinal side effects were the most commonly reported events in the semaglutide 2.4mg group. Nausea topped the list, but reflux, burping and indigestion featured consistently. The NHS entry for semaglutide on its medicines pages categorises indigestion and reflux as common side effects, meaning they affect somewhere between one in ten and one in a hundred people. That framing is useful: common does not mean inevitable, and it does not mean permanent.

The biological reason is straightforward. Semaglutide activates GLP-1 receptors in the gut wall, which signals the stomach to contract more slowly. Food and stomach acid sit together for longer than they would otherwise. If any of that mixture moves back towards the oesophagus, you feel the burn. If you are wondering specifically whether semaglutide can give you heartburn, the short answer is yes, and the effect is usually most pronounced when doses go up, because a higher dose produces a stronger slowing effect. That is why reflux can reappear at 1mg or 1.7mg even if it had already settled at 0.5mg.

There is no clinical evidence that semaglutide damages the oesophagus in otherwise healthy adults, but untreated reflux that persists for weeks is worth flagging. A detailed look at Wegovy's full side-effect profile is a good starting point before your next prescriber conversation.

The practical habits that reduce heartburn on semaglutide

Because gastric slowing is the underlying driver, the habits that help are the ones that reduce how much acid is produced and how long it stays in contact with the oesophagus. Smaller meals are probably the single most effective change: a stomach that is not overfull has less pressure pushing acid upward. Eating more slowly helps too, semaglutide already reduces appetite substantially, so the urge to finish a large plate usually diminishes anyway.

Timing matters. Lying down within two or three hours of eating gives acid a gravitational advantage it would not otherwise have. If evening reflux is the problem, shifting the main meal earlier in the day often resolves it without any medicine change. Fatty foods, fried food, carbonated drinks, coffee and anything acidic slow gastric emptying further and lower the pressure in the sphincter that keeps acid in the stomach, reducing them during the adjustment phase is worth trying before concluding heartburn is unmanageable.

One quick check that takes under a minute: prop yourself up slightly in bed by raising the head of the mattress a few inches or adding an extra pillow under your shoulders, not just your head. Many people find this alone cuts overnight reflux significantly. It costs nothing and you will notice within a night or two whether it helps. More background on whether Wegovy causes heartburn covers similar ground if you want to read further before your next review.

When to speak to your prescriber, and what they can do

Mild, occasional heartburn that responds to the habits above is not a reason to stop treatment. But certain patterns deserve a clinical conversation sooner rather than later. Symptoms that are severe enough to interrupt sleep, make eating painful, or show no sign of easing after a couple of weeks at a stable dose should be reviewed. The same applies if you develop difficulty swallowing, which is not a typical GLP-1 symptom and needs assessment on its own terms.

A prescriber has several options. Slowing the titration schedule (spending longer at a lower dose before moving up) is a common and effective approach. Dose reduction is sometimes considered where reflux is significantly affecting quality of life. Over-the-counter antacids can be used alongside treatment, though any new regular medicine, including pharmacy antacids, is worth mentioning at your next review. A prescriber will not simply tell you to push through something that is making treatment miserable. If you are considering starting Wegovy and want to understand the full picture first, our Wegovy overview covers the treatment in detail. Those interested in how cost factors into the decision can find context on the Wegovy pricing page.

Our clinical team reviews every consultation personally. If heartburn from semaglutide treatment is already something you are dealing with, bringing it up at your next check-in is the right move, prescribers at nume hear this question regularly and have practical answers. If you have not yet started and want to discuss whether treatment is suitable for you, start your free consultation and a prescriber will review your case the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions